T2 Biosystems Inc., a Lexington, Mass.-based developer of diagnostics for rapid identification of dangerous pathogens, has reached a key regulatory milestone…
Operator: Good day and thank you for standing by. Welcome to the Profound Medical Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.